The divergence between gross and operating margin trends is notable: gross margin declined by roughly 440 basis points over the ten-quarter window, yet operating margin fell by approximately 680 basis points, implying that SG&A has not scaled down in proportion to revenue contraction. The anomalous 2025Q3 quarter, where net margin collapsed to 0.3%, likely reflects a non-recurring charge and should be excluded from run-rate earnings power estimates. Normalizing for that quarter, trailing net margin appears closer to 7.5-8%, still meaningfully below the 12.2% recorded in 2024Q2, indicating that true earning power has degraded rather than merely been obscured by a one-time item.

This ROIC compression appears driven primarily by margin erosion rather than capital inefficiency, as asset turnover has remained remarkably stable at 0.21-0.23 across all ten quarters. The implication is that the capital deployed in pressure pumping fleets and international operations is not being retired despite deteriorating returns, suggesting Halliburton may be over-investing relative to current demand conditions. ROE has similarly fallen from 7.2% to 3.8%, well below the double-digit ROE reported by both SLB (10.3%) and BKR (16.1%), indicating a structural gap in capital productivity relative to more internationally diversified peers.

The wide gap between trailing and forward multiples suggests investors are underwriting a cyclical rebound in North American completions pricing, which would require either a stabilization of the frac spread count or meaningful service intensity gains from longer laterals. If the reported TTM net margin of 5.8% persists into forward periods rather than recovering toward the 8-9% range implied by the forward multiple, the current valuation would appear stretched rather than discounted. The P/B of 2.79, compared with SLB at 2.89 and BKR at 2.92, is difficult to justify given Halliburton's materially lower ROIC, warranting scrutiny of whether the market is applying a diversified-services multiple to what is structurally a more cyclical North American exposure.

The trajectory from 0.87 to 0.73 in D/E appears to reflect genuine debt reduction from $8.7B to $8.2B rather than solely equity accretion, which is a constructive signal even as the equity base expanded from $10.0B to $11.1B. However, D/EBITDA of 8.91 in 2026Q3 is elevated relative to the 6.70-7.85 range seen in healthier quarters, suggesting that EBITDA compression rather than new borrowing is the primary driver of leverage optics deteriorating on a cash-flow basis. The reported interest coverage of 7.11x, while adequate, fell from 9.00x in 2026Q2 and remains well below the 42.15x anomaly in 2025Q4, indicating coverage is sensitive to quarterly earnings volatility in a way that more diversified peers are not.

The stability of asset turnover at 0.22 across all ten quarters is striking given the 3.3% TTM revenue decline, implying the asset base is being managed in line with activity rather than accumulating idle capacity. However, DSO of 87 days in 2026Q3 represents the highest reading in the period and sits above the 81-day level in 2024Q2, which may indicate customer payment terms are lengthening as E&P buyers consolidate and gain negotiating leverage. The CCC improvement appears driven by stretching DPO to 66 days from the 62-day level seen consistently through 2025, a tactic that may not be sustainable if suppliers tighten terms in response to Halliburton's own working capital pressures.